Announcements
Projects
Orgs
Project

Join Merck.com

Create your account and become a member of this amazing organization

About Merck.com
0
Members
16
Articles

Create Your Account & Join

Personal Information
Account Information
Leave blank if you prefer not to use a username
Security
6 characters minimum
What happens when you join?
  • Your account will be automatically created and confirmed
  • You'll be immediately added to Merck.com
  • You'll be signed in automatically
  • Organization admins will be notified of your membership
  • You can start participating right away!

Already have an account?

Sign In Join with Existing Account
Recent Content from Merck.com
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results - Merck.com
Oct 30, 2025
U.S. FDA Approves Updated Indication for WINREVAIR™ (sotatercept-csrk) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension) Based on Phase 3 ZENITH Study - Merck.com
Oct 27, 2025
Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Pretreated Extensive-Stage Small Cell Lung Cancer - Merck.com
Aug 18, 2025